COMPASS THERAPEUTICS INC's ticker is CMPX and the CUSIP is 20454B104. A total of 74 filers reported holding COMPASS THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,574,532 | -38.1% | 2,829,712 | 0.0% | 2.21% | -19.1% |
| Q2 2023 | $8,998,484 | -2.8% | 2,829,712 | 0.0% | 2.73% | +11.2% |
| Q1 2023 | $9,253,158 | -35.0% | 2,829,712 | 0.0% | 2.46% | -35.2% |
| Q4 2022 | $14,233,452 | +120.6% | 2,829,712 | 0.0% | 3.79% | +118.5% |
| Q3 2022 | $6,452,000 | -14.0% | 2,829,712 | 0.0% | 1.74% | -39.4% |
| Q2 2022 | $7,499,000 | +93.4% | 2,829,712 | 0.0% | 2.86% | +73.7% |
| Q1 2022 | $3,877,000 | -59.6% | 2,829,712 | -6.4% | 1.65% | -48.2% |
| Q4 2021 | $9,585,000 | – | 3,023,692 | – | 3.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management V, LLC | 4,400,000 | $22,132,000 | 17.19% |
| Monashee Investment Management LLC | 2,230,441 | $11,219,000 | 4.83% |
| CHI Advisors LLC | 2,829,712 | $14,233,452 | 3.79% |
| CAXTON CORP | 211,159 | $1,062,132 | 2.71% |
| Orbimed Advisors | 22,362,850 | $112,485,136 | 2.15% |
| Vivo Capital, LLC | 3,557,630 | $17,895 | 2.06% |
| DAFNA Capital Management LLC | 602,051 | $3,028,316 | 0.85% |
| Rock Springs Capital Management LP | 5,333,188 | $26,825,936 | 0.64% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 268,307 | $1,349,584 | 0.39% |
| BRAIDWELL LP | 1,814,266 | $9,125,758 | 0.31% |